General Motors Co. (0R0E)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 82.61 |
|---|---|
| 52-week range | 53.10 – 91.63 |
| Return, 1 month / 3 months | −5.2% / +7.9% |
| Return, 1 year / 3 years | +49.5% / +155.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 50 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -16.3% |
| Average daily value traded | 0.71M USD |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
General Motors is an American automaker based in Detroit, Michigan. It designs, builds and markets cars, trucks and sport utility vehicles under brands such as Chevrolet, GMC, Cadillac and Buick, serving retail customers and fleet buyers in North America and other markets around the world. The company also offers vehicle financing through its financial services arm and is developing electric vehicles and self-driving technology.
General Motors Co. trades under the code 0R0E on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
General Motors Co. (0R0E) trades on the London Exchange in UK. It last closed at USD 82.61 on 19 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,078 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 49.5% and over the last three months it rose 7.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.6% | ||
| From 52-week high | -9.2% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.9% | ||
| 6-month return | 6.0% | ||
| 12-month return, skipping the last month | 57.7% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.3% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.71M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | −5.2% |
| 3 months | +7.9% |
| 6 months | +6.0% |
| 1 year | +49.5% |
| 3 years | +155.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 84.36 / 80.48 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | USD 0.1800 |
| 4 Jun 2026 | USD 0.1800 |
| 5 Mar 2026 | USD 0.1800 |
| 4 Dec 2025 | USD 0.1500 |
| 4 Sep 2025 | USD 0.1500 |
| 5 Jun 2025 | USD 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.